| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $329K | +3.9% |
| SG&A Expense | $11.5M | +101.5% |
| Operating Income | -$10.5M | -84.5% |
| Interest Expense | $237K | — |
| Pre-tax Income | -$10.3M | -216.4% |
| Income Tax | $166K | -61.5% |
| Net Income | -$2.7M | +25.8% |
| EPS (Diluted) | -$0.45 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.8M | — |
| Current Assets | $29.3M | — |
| Total Assets | $31.9M | -82.1% |
| Current Liabilities | $2.5M | -66.9% |
| Total Liabilities | $3.1M | -73.6% |
| Stockholders' Equity | $28.8M | +365.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | -645.4% |
| Capital Expenditures | $59K | +1228.2% |
| Investing Cash Flow | -$59K | +94.7% |
| Financing Cash Flow | $37.5M | +1822.8% |
| Free Cash Flow | -$9.2M | -647.5% |